These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 10846831

  • 21. Evaluating the risk of hepatitis B reactivation in patients with haematological malignancies: is the serum hepatitis B virus profile reliable?
    Ferraro D, Pizzillo P, Di Marco V, Vultaggio A, Iannitto E, Venezia G, Craxì A, Di Stefano R.
    Liver Int; 2009 Sep; 29(8):1171-7. PubMed ID: 19602139
    [Abstract] [Full Text] [Related]

  • 22. Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B virus carriers with hematologic malignancies.
    Ohtsu T, Sai T, Oka M, Sugai Y, Tobinai K.
    Jpn J Clin Oncol; 1991 Oct; 21(5):360-5. PubMed ID: 1753416
    [Abstract] [Full Text] [Related]

  • 23. Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma.
    Cheng AL, Hsiung CA, Su IJ, Chen PJ, Chang MC, Tsao CJ, Kao WY, Uen WC, Hsu CH, Tien HF, Chao TY, Chen LT, Whang-Peng J, Lymphoma Committee of Taiwan Cooperative Oncology Group.
    Hepatology; 2003 Jun; 37(6):1320-8. PubMed ID: 12774010
    [Abstract] [Full Text] [Related]

  • 24. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Huang H, Cai Q, Lin T, Lin X, Liu Y, Gao Y, Peng R.
    Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
    [Abstract] [Full Text] [Related]

  • 25. Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.
    Leaw SJ, Yen CJ, Huang WT, Chen TY, Su WC, Tsao CJ.
    Ann Hematol; 2004 May; 83(5):270-5. PubMed ID: 15060745
    [Abstract] [Full Text] [Related]

  • 26. Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies.
    Kawatani T, Suou T, Tajima F, Ishiga K, Omura H, Endo A, Ohmura H, Ikuta Y, Idobe Y, Kawasaki H.
    Eur J Haematol; 2001 Jul; 67(1):45-50. PubMed ID: 11553266
    [Abstract] [Full Text] [Related]

  • 27. Hepatitis B virus reactivation in adjuvant chemotherapy for breast cancer.
    Ide Y, Ito Y, Takahashi S, Tokudome N, Kobayashi K, Sugihara T, Hattori M, Yokoyama M, Uchiyama A, Inoue K, Sakurai N, Hatake K.
    Breast Cancer; 2013 Oct; 20(4):367-70. PubMed ID: 20658270
    [Abstract] [Full Text] [Related]

  • 28. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.
    Esteve M, Saro C, González-Huix F, Suarez F, Forné M, Viver JM.
    Gut; 2004 Sep; 53(9):1363-5. PubMed ID: 15306601
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies.
    Lalazar G, Rund D, Shouval D.
    Br J Haematol; 2007 Mar; 136(5):699-712. PubMed ID: 17338776
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis.
    Yeo W, Chan PK, Chan HL, Mo FK, Johnson PJ.
    J Med Virol; 2001 Nov; 65(3):473-7. PubMed ID: 11596081
    [Abstract] [Full Text] [Related]

  • 34. Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab.
    Miyagawa M, Minami M, Fujii K, Sendo R, Mori K, Shimizu D, Nakajima T, Yasui K, Itoh Y, Taniwaki M, Okanoue T, Yoshikawa T.
    J Med Virol; 2008 Dec; 80(12):2069-78. PubMed ID: 19040281
    [Abstract] [Full Text] [Related]

  • 35. Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention.
    Mindikoglu AL, Regev A, Schiff ER.
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1076-81. PubMed ID: 16861051
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Fulminant hepatic failure and hepatitis B virus reactivation: case reports and analyses of the pathological mechanism].
    Tian Y, Gong G.
    Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):272-6. PubMed ID: 25173225
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma.
    Perceau G, Diris N, Estines O, Derancourt C, Lévy S, Bernard P.
    Br J Dermatol; 2006 Nov; 155(5):1053-6. PubMed ID: 17034541
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.